These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8538634)

  • 1. Animal models for breast cancer.
    Sukumar S; McKenzie K; Chen Y
    Mutat Res; 1995 Dec; 333(1-2):37-44. PubMed ID: 8538634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors.
    McKenzie KE; Armstrong BA; Chen Y; Nagarajan M; Aldaz CM; Sukumar S
    Mol Carcinog; 1997 Oct; 20(2):194-203. PubMed ID: 9364209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors.
    Sgambato A; Han EK; Zhang YJ; Moon RC; Santella RM; Weinstein IB
    Carcinogenesis; 1995 Sep; 16(9):2193-8. PubMed ID: 7554074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats.
    Zarbl H; Sukumar S; Arthur AV; Martin-Zanca D; Barbacid M
    Nature; 1985 May 30-Jun 5; 315(6018):382-5. PubMed ID: 3923365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of O6-methylguanine-DNA methyltransferase mRNA levels in Ha-ras mutated and non-mutated rat mammary tumors induced by N-methyl-N-nitrosourea.
    Inui H; Watatani M; Yasutomi M; Nishisho I
    Carcinogenesis; 1994 Mar; 15(3):459-63. PubMed ID: 8118929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
    Tsuda H; Asamoto M; Ochiya T; Toriyama-Baba H; Naito A; Ota T; Sekiya T; Terada M
    Mutat Res; 2001 Jun; 477(1-2):173-82. PubMed ID: 11376698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
    Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
    Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis.
    Asamoto M; Ochiya T; Toriyama-Baba H; Ota T; Sekiya T; Terada M; Tsuda H
    Carcinogenesis; 2000 Feb; 21(2):243-9. PubMed ID: 10657964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of p53 mutations in methylnitrosourea-induced mammary tumors in rats.
    Ogawa K; Tokusashi Y; Fukuda I
    Cancer Detect Prev; 1996; 20(3):214-7. PubMed ID: 8769715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulation of the cyclin D1/Cdk4 retinoblastoma pathway in rat mammary gland carcinomas induced by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Qiu C; Shan L; Yu M; Snyderwine EG
    Cancer Res; 2003 Sep; 63(18):5674-8. PubMed ID: 14522882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the farnesyltransferase inhibitor R115777 in a rat mammary tumor model: role of Ha-ras mutations and use of microarray analysis in identifying potential targets.
    Yao R; Wang Y; Lu Y; Lemon WJ; End DW; Grubbs CJ; Lubet RA; You M
    Carcinogenesis; 2006 Jul; 27(7):1420-31. PubMed ID: 16403772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ha-ras-1 oncogene mutations in mammary epithelial cells do not contribute to initiation of spontaneous mammary tumorigenesis in rats.
    Cha RS; Guerra L; Thilly WG; Zarbl H
    Carcinogenesis; 1996 Nov; 17(11):2519-24. PubMed ID: 8968072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations in HCA-induced tumors.
    Ushijima T; Makino H; Kakiuchi H; Inoue R; Sugimura T; Nagao M
    Princess Takamatsu Symp; 1995; 23():281-91. PubMed ID: 8844820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas.
    Stoesz SP; Gould MN
    Oncogene; 1995 Dec; 11(11):2233-41. PubMed ID: 8570173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in H-ras1 promoter conformation during N-nitroso-N-methylurea-induced mammary carcinogenesis and pregnancy.
    Jin Z; Houle B; Mikheev AM; Cha RS; Zarbl H
    Cancer Res; 1996 Nov; 56(21):4927-35. PubMed ID: 8895746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations.
    Cha RS; Thilly WG; Zarbl H
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3749-53. PubMed ID: 8170982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Ha-ras oncogenes in growth factor independence in rat mammary carcinoma cells.
    Chiodino C; Jones RF; Ethier SP
    Mol Carcinog; 1991; 4(4):286-96. PubMed ID: 1908245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations.
    Sukumar S; Notario V; Martin-Zanca D; Barbacid M
    Nature; 1983 Dec 15-21; 306(5944):658-61. PubMed ID: 6318112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats.
    Thompson TA; Haag JD; Gould MN
    Carcinogenesis; 2000 Oct; 21(10):1917-22. PubMed ID: 11023551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.